Navigation Links
Bard® PerFix® Plug

ProductsBard® PerFix® Plug
Company Davol, Inc.
Item Bard® PerFix® Plug
Features 
  • The entire operation can take twenty-five minutes or less
  • Patients have far less pain
  • Virtually eliminates recurrence
  • No other mesh product stands up to the Bard® PerFix® plug
  • Efficacy you can truly count on
  • Description The Bard PerFix plug technique, recommended for the treatment of all primary and recurrent indirect and direct inguinal hernias, provides significant advantages over a conventional suture technique, requiring less overall dissection and is utilized in a complete tension-free repair technique. The result is increased patient comfort, fast rehabilitation, and fewer recurrences. The entire operation can take 25 minutes or less.* In addition, the technique offers significant time and cost-saving benefits. The tapered shape of the PerFix plug eases insertion into the hernia defect, while the pre-shaped onlay patch accommodates the anatomy of the inguinal canal. This ready-to-use plug design minimizes any need to tailor perioperatively. The entire operation takes less time from incision to dressing placement. Technical simplicity means general anesthesia is not required.
    Info Davol, Inc.
    Customer Service: (800) 556-6756
    Web site: http://www.davol.com/

    Related medicine products :

    1. Bard® Composix® E/X Mesh
    2. Bard® Channel Drain
    3. Bard® 4-Channel Urodynamic System
    4. Bard® Magnum® Instrument and Needle
    5. Bard® Magnum® Instrument Needles
    6. Bard® Monopty® Instrument
    7. Bard® MaxCore™ Instrument and Needle
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    Medicine Products:
    (Date:7/29/2014)... July 29, 2014 (HealthDay News) --,The time at which ... their chances for survival, new research suggests. Showing ... or during holidays is associated with a 13 percent ... hours, researchers report. Every year, more than 250,000 ... severe type of heart attack, which is caused by ...
    (Date:7/29/2014)... 2014 (HealthDay News) -- Chlorine helps keep pool water ... to develop eye infections, doctors say. Pool ... as blurry vision, said Dr. Sampson Davis, an emergency ... Jersey. It,s important to understand why this happens, ... the outer film layer of the eye that helps ...
    (Date:7/29/2014)... Las Vegas, Nevada (PRWEB) July 29, 2014 ... has reappointed Holland & Hart LLP ’s Connie ... Bar Foundation. She currently serves as President of the Foundation. ... from 2011-2012. , Akridge is a partner at Holland & ... variety of litigation and regulatory/administrative matters to insurance and healthcare ...
    (Date:7/29/2014)... 2014 Tylenol lawsuits ( http://www.tylenollawsuitclaims.com/ ... suffered serious liver injuries due to the acetaminophen ... a multidistrict litigation underway in U.S. District Court, ... According to an Order dated July 23rd, the ... bellwether case and discovery issues. Among other things, ...
    (Date:7/29/2014)... Dennis Thompson HealthDay Reporter , ... diet and good sleep can protect the body against the ... at a cellular level, researchers report. A study involving ... to increased shortening of telomeres, the protective caps at the ... "We found that over a one-year period, the more stressors ...
    Breaking Medicine News(10 mins):Health News:Heart Attack Patients Treated at Night, Weekends May Have Worse Outcomes 2Health News:Protect Your Eyes When Hitting the Pool 2Health News:Holland & Hart LLP Attorney Connie Akridge Reappointed Trustee of the Nevada Bar Foundation 2Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 2Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 3Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 4Health News:Healthy Habits May Slow Cellular Signs of Aging, Study Finds 2Health News:Healthy Habits May Slow Cellular Signs of Aging, Study Finds 3
    ... estimated that as,many as 40 percent of all people ... of all children with lupus, will develop kidney,complications that ... Kidney Month and the Lupus Foundation of America,(LFA) is ... and,potentially life-threatening complication of lupus. The LFA will conduct ...
    ... guideline on colorectal cancer screening released today by ... health care organizations, including the American College of ... (ASGE) and the American Cancer Society (ACS), offers ... and states a strong preference for screening tests ...
    ... 6 Pregis Corporation, a leading,international manufacturer, ... specialty packaging solutions, will conduct an investor,conference ... and full year results on,Thursday, March 20, ... CT). The call can be,accessed through the ...
    ... ARLINGTON, Va., March 6 Champions,Biotechnology, Inc. (OTC Bulletin ... third quarter financial results.,Full details of the Company,s financial ... http://www.sec.gov , For the three months ended January ... earnings per share of $0.02 compared to a net ...
    ... up 23%, Adjusted EBITDA up 33%, TORONTO, March ... leading provider of products and services to the global ... For the,quarter, MDS reported net revenues of $296 million, ... continuing operations of $0.14.,Adjusted EBITDA rose to $40 million, ...
    ... The Board of Directors of Essilor International, the world leader in,ophthalmic optical products, today announced its audited financial results,for the ... 2007 ... 2,908.1 ... 482.6 + 9.3%, As a % of revenue ...
    Cached Medicine News:Health News:Lupus Foundation of America Webchat to Discuss Kidney Disease in Lupus 2Health News:New guidelines update recommendations on colorectal cancer screening 2Health News:New guidelines update recommendations on colorectal cancer screening 3Health News:New guidelines update recommendations on colorectal cancer screening 4Health News:Champions Biotechnology, Inc. Reports Two Cents per Share Earnings for Three Quarters Ended January 31, 2008 2Health News:Champions Biotechnology, Inc. Reports Two Cents per Share Earnings for Three Quarters Ended January 31, 2008 3Health News:MDS Reports First Quarter 2008 Results 2Health News:MDS Reports First Quarter 2008 Results 3Health News:MDS Reports First Quarter 2008 Results 4Health News:MDS Reports First Quarter 2008 Results 5Health News:MDS Reports First Quarter 2008 Results 6Health News:MDS Reports First Quarter 2008 Results 7Health News:MDS Reports First Quarter 2008 Results 8Health News:MDS Reports First Quarter 2008 Results 9Health News:MDS Reports First Quarter 2008 Results 10Health News:MDS Reports First Quarter 2008 Results 11Health News:MDS Reports First Quarter 2008 Results 12Health News:MDS Reports First Quarter 2008 Results 13Health News:MDS Reports First Quarter 2008 Results 14Health News:MDS Reports First Quarter 2008 Results 15Health News:MDS Reports First Quarter 2008 Results 16Health News:MDS Reports First Quarter 2008 Results 17Health News:MDS Reports First Quarter 2008 Results 18Health News:MDS Reports First Quarter 2008 Results 19Health News:MDS Reports First Quarter 2008 Results 20Health News:MDS Reports First Quarter 2008 Results 21Health News:MDS Reports First Quarter 2008 Results 22Health News:MDS Reports First Quarter 2008 Results 23Health News:MDS Reports First Quarter 2008 Results 24Health News:MDS Reports First Quarter 2008 Results 25Health News:MDS Reports First Quarter 2008 Results 26Health News:MDS Reports First Quarter 2008 Results 27Health News:MDS Reports First Quarter 2008 Results 28Health News:MDS Reports First Quarter 2008 Results 29Health News:MDS Reports First Quarter 2008 Results 30
    (Date:7/29/2014)... Cynosure, Inc. (Nasdaq: CYNO ), ... systems for high-volume applications, today reported financial results for ... financial results incorporate the acquisition of Palomar Medical Technologies, ... Second-Quarter 2014 Financial Highlights ... , Non-GAAP net income of $7.1 million, or $0.32 ...
    (Date:7/29/2014)... --   What:   AFFiRiS AG, ... from a Phase I clinical trial of PD01A, a ... disease progression. The Michael J. Fox Foundation supported the ... the impact of the results for patients and the ... 2014         11.00 am ...
    (Date:7/29/2014)... 2014  Drug development for hepatitis C virus ... and the intense need for curative therapy in ... underway as the market moves away from protease ... interferon-free oral therapies. Logo - ... blockbuster Sovaldi is the first of these novel ...
    Breaking Medicine Technology:Cynosure Reports Second-Quarter 2014 Financial Results 2Cynosure Reports Second-Quarter 2014 Financial Results 3Cynosure Reports Second-Quarter 2014 Financial Results 4Cynosure Reports Second-Quarter 2014 Financial Results 5Cynosure Reports Second-Quarter 2014 Financial Results 6Cynosure Reports Second-Quarter 2014 Financial Results 7Cynosure Reports Second-Quarter 2014 Financial Results 8Cynosure Reports Second-Quarter 2014 Financial Results 9Cynosure Reports Second-Quarter 2014 Financial Results 10Cynosure Reports Second-Quarter 2014 Financial Results 11Cynosure Reports Second-Quarter 2014 Financial Results 12Reminder/Media Advisory/AFFiRiS AG Presents Early Clinical Data on a First-of-its-Kind Parkinson's Disease Vaccine 2A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 2A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 3A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 4